













































































































































































































































































Fig･ 2-1 Glucose tolerance test in OLETF rats at diflierent ages. Rats at 10 (O), 40 (A),
Or 48 (D) weeks of age, which had been fasted for 16 h, were given glucose (1 glkg body
Weight) orally, and the plasma glucose level was followed after the administration of
glucose. Data are presented as mean of four rats (± SEM). "P < O.05 compared with 10-
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Fig･ 2-2 Sucrase and isomaltase activities in the smal1 intestine of OLE'II and LETO rats
at different ages. The activities of sucrase and isomaltase in LETO (open bars) and OLETF
(SOlidbars) rats were determined as described in Section 2-2. Data are presented as mean
± SEM (n=5). "P < O.05 compared with 10-week-old rats in each strain. #P < O.05
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Fig. 2-3 Western blot analysis of the SI complex in OIJi'IF and IETO rats at different
ages. The expression levels of the sucrase and isomaltase subunits of the SI complex were
examined by immunoblotting using an antiserum against rat SI complex as described in
Section 2-2. (A) Representative immunoblot showing the sucrase and isomaltase subunks
in OIETF and IETO rats at different ages. (B) Immunoblots of the sucrase and isomaltase
subunits are quantified by scanning densitometry. Data (n=5, ± SEM) are presented as
relative values (fold of the level of 10-week-old LETO rats). *P < O.05 cornpared with 10-
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Fig. 2-4 Expression level of mRNA for the SI complex in OIMF and LETO rats at
different ages. Nonhern blotting was done as described in Section 2-2. (A) Representative
Nonhern blots showing mRNA for the SI complex. (B) Nonhern blots are quantified by
scanning densitometry. Data (n=5, ± SE]VD are normalized with B-actin mRNA level and
are presented as relaive values (fold of the level of 10-week-old LETO rats).*P < O.05






































































































































































































Table 3- 1 Body weight (BW), plasma glucose (PG), insulin and HbA,, levels

































 89 ± 11#
192 ± 18
















Data are expressed as means ± SEM Each group of n=5. "P<O.Ol, #P<O.05 vs age
matched control rats.
28
Table3 - 2 Vilti length and mucosal protein content



















3.0 ± O. 1#
2.4 ± O. 1















2.6 ± O. 1
4.8 ± O. 1*
4.1±O.1
Data are expressed as
matched control rats.









































Fig. 3-1 Mbrphology of small intesime. Srz rat and control Wistar rat are shown in (A)
and (B), respectively. orErlF rat and control LETO rat are in (C) and (D) at 10-woek-old,
and (E) and (F) at 30-week-old, respectively. GK rat and control Wistar rat are in (G) and
(H) at 10-week-old, and (I) and (J) at 20-week-old, respectively. Original magnification x
40. Bar: 2oo pm.
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Fig. 3-2 Specific activities (A) and total activities (B) of sucrase and isomaltase in the
small intestine. The specific and total activities of sucrase and isomaltase in STZ, OLETF,
GK (solid bars) and each control group of rats (open bars) rats at different ages are
determined as described in section 3-2. Data are presented as mean ± SEM (n=5). W;
Wistar rats, S; STZ rats, G; GK rats, L; LETO rats, O; OLETF rats. *P < O.Ol, #P<O.05,
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Fig. 3-3 Expression of SI complex protein (A) and mRNA(B). (A) Expression levels of
the sucrase and isomaltase subunits. Immunoblots of the sucrase and isomaltase subunits
are quantified by scanning densitometry. Relative intensity of isomaltase subunit
expression was calculated and the expression in age-matched each control rats was
normalized as 1. (B) Expression level of mRNA for the SI complex. Nonhern blots are
quantified by scanning densitometry. Relative intensity of SI mRNA expression was
calculated against each beta-acim mRNAexpression, and the expression in age-matched
each control rats was normalized as 1. Data (n=5, ± SEM) are presented as relative values
(-fold of the level of respective age-matehed control rats). W; Wistar rats, S; Srz rats, G;
GK rats, L; LETO rats, O OIETF rats. 'P < O.Ol, #P < O.05 compared with with age-


































Fig. 3-4 IMmunohistochemistry with SI in the smal1 intestine. STZ rat and contro1 Wistar
rat are shown in (A) and (B), respectively. OIJiTF rat and control LETO rat are in (C) and
(D) at 10-week-old, and (E) and (F) at 30-week-old, respectively. GK rat and control
Wistar rat are in (G) and (H) at 10-week-old, and (I) and (J) at 20-week-old, respectively.
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Fig. 3-5 Quantitative RT-PCR analysis of Cdx 1 and 2 in small intesimal mRNA.
Relative intensity of Cdx 1 and 2 mRNAexpression was calculated against each beta-actin
mRNAexpression, and the expression in age-rnatehed each control rats was normalized as
1. Data (n=5, ± SEM) are presented as relative values (fold of the level of age-matehed
each control rats). W; Wistar rats, S; STZ rats, G; GK rats, L; LETO rats, O; OLETF rats.
































































































Fig. 4-1 Structure ofT-1095.









































































































Table 4-1. Body weight,
STZ and T-1095 rats
plasma glucose,and HbAi,levelsin normal Wistar control,

















  4.8 ± O.1
  5.7 ±O.1
  5.0 ± O.1
  5.3 ± O.1
  5.1 ±O.1
192.4 ± 3.1
200.3 ± 2.6 g
175.0 ± 4.2 g
155.5 ± 5.4 g
 18.4 ± O.4 g
 28.9 ± 1.0 g
 26.4 ± 1.2 g
 14.o ± o.s g
 17.o ± o.s g
1895 ± 5.2
197.8 ± 2.3 g
201.5 ± 3.8 gt
189.2 ± 11.2 gt
 18.9 ± O.4 g
 14.1 ± O.2 g#
 15.8 ± 1.3 g$
  8.8 ± O.4 g#
  9.2 ± O.8 g#
-1 week shows the week of administration of STZ, and O week shows a week after the
administration of STZ and before the beginning of administration of T-1095. Data are
expressed as means ± SEM Normal Wistar rats n=10, STZ and T-1095 rats n=8
respectively at -1 and O week, and normal Wistar rats n=5, STZ and T-1095 rats n=4 at 4
and 8 week. gP<O.OOI vs normal Wistar rats, tP<O.05, #P<O.OOI, $P<O.Ol vs STZ rats,
respectively.
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Table 4-2. Kidney weight, kidney weight as a percentage of body weight (KWIBW),
urinary glucose and albumin excretion in normal Wistar control, STZ, and T-1095 rats
after 8 weeks.
Normal STZ T-- 1095
Kdney weight (g)
KW/BW(%)
Urinary glucose excretion (mg/24hr)





2.45 ± O.18 *
1.57 ± O.09 g
7546 ± 270 g
1649 ± 200 g
2.18 ± O.06
1.27 ± O.02 Y
8687 ± 336 Y
781 ± 156 M
Data are expressed as means ± SEM Normal Wistar rats n=5, STZ and T-1095 rats n=4.































Fig. 4-2 Hematoxylm and eosin (HE)-stained histological sections from kidney.
Photomicrographs of kidney from norinal Wistar control (A), Srz (B), and T-1095 (C)
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Fig. 4-3 Expression of renal SGLTI, SGLT2, and GLUT2 mRNA (A), and SGLTI
and GLUT2 protein (B) in normal Wistar control, Srz, and T-1095 rats 8 weeks after
administration, respectively. (A) Nonhern blot analysis of glucose transporters. A beta-
actin cMslA served as control hybridization. Relative intensity ofeach glucose transpomer
mRNA expression was calculated against each beta-actin mRNA expression, and the
expression of normal Wistar rats was normalized as 1. (B) Immunoblot analysis of
SGLTI and GLUT2 in each group of rats. Relative intensity of each glucose transporter
protein expression was calculated and the expression in norrnal Wistar rats was normalized
as 1. Each bar represents the mean ± SEM N; normal Wistar rats, S; Srz rats, T; T-1095
rats. Normal Wistar rats; n=5, S'IZ rats; n=4, T-1095 rats; n=4. *; P<O.05, vs normal
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Fig. 4-4 Expression of intestinal SGLTI and GLUT2 mRNA (A) and protein (B) in
normal Wistar control, STZ, and T-1095 rats 8 weeks after administration. (A) Nomhern
blot analysis of SGLTI and GLUT2. Relative intensity ofeach glucose transporter mRNA
is calculated as the expression of normal Wistar rats to 1. A beta-actin cDNA served as
control hybridization. (B) Immuno blot analysis of SGLTI and GLUT2. Relative intensity
of each glucose transporter protein was calculated and the expression of normal Wistar rats
was normalized as 1. Each bar represents the mean ± SEM. N; normal Wistar rats, S; Srz
rats, T; T-1095 rats. Normal Wistar rats; n=5, STZ rats; n=4, T-1095 rats; n=4. *;

























Fig. 4-5 lvforphological change of srnall intestine. Hematoxylm and eosin (HE)-stained
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